Hap Trading, LLC Nektar Therapeutics Call Options Transaction History

Hap Trading, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	SELL	$13.07 - $18.84 $337,206 - $486,072	-25,800 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$16.52 - $20.4 $426,216 - $526,320	25,800 New	25,800 $14,000
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $192,095 - $295,336	-11,600 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $6,308 - $7,612	-400 Reduced 3.33%	11,600 $0
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $126,084 - $188,404	-7,600 Reduced 38.78%	12,000 $6,000
Q2 2020 Aug 10, 2020	SELL	$16.86 - $23.44 $72,498 - $100,792	-4,300 Reduced 17.99%	19,600 $12,000
Q1 2020 May 08, 2020	SELL	$14.47 - $27.96 $170,746 - $329,928	-11,800 Reduced 33.05%	23,900 $15,000
Q4 2019 Feb 11, 2020	BUY	$15.87 - $23.12 $44,436 - $64,736	2,800 Added 8.51%	35,700 $27,000
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $556,339 - $1.19 Million	32,900 New	32,900 $20,000
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $564,200 - $660,660	-18,200 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$31.58 - $46.35 $691,602 - $1.02 Million	-21,900 Reduced 54.61%	18,200 $4,000
Q4 2018 Feb 12, 2019	BUY	$30.43 - $56.65 $562,955 - $1.05 Million	18,500 Added 85.65%	40,100 $52,000
Q3 2018 Nov 09, 2018	SELL	$46.46 - $68.49 $17.2 Million - $25.3 Million	-370,100 Reduced 94.49%	21,600 $214,000
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $17.9 Million - $40.4 Million	386,400 Added 7290.57%	391,700 $210,000
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $304,220 - $574,732	5,300 New	5,300 $326,000

147

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.